InvestorsHub Logo
Followers 2
Posts 221
Boards Moderated 0
Alias Born 05/21/2008

Re: None

Thursday, 10/27/2011 10:34:16 AM

Thursday, October 27, 2011 10:34:16 AM

Post# of 4094
I will not post my email to Dr Owen suffice to say that it was rather harsh; but below was his answer, and I can only say that it was good of him to reply.



Your e-mail below was passed on to me. I have responded to both e-mail addresses provided.

We can only report news as it happens, such as the recent announcement about the new NPN for hydrocortisone ointment.

As disclosed in recent quarterly reports, the market for hand sanitizers, which had been our main source of revenue during the 2010 fiscal year, dropped unexpectedly and precipitously during 2011. Other producers have faced the same problem.

The global financial turmoil has affected small cap companies particularly severely, even those in the gold sector. This has led to lower share prices and a shortage of capital.

The company has developed a significant portfolio of intellectual property and we are working very hard on pulling the company through these difficult times and are seeking to regain value for shareholders from this asset.

Having been in public companies since 1987, I can comment that the these are the most difficult times that I have seen despite having survived many previous downturns.

Regards,

Terry Owen

--



Full contact info:
Terrance G. Owen, Ph.D., M.B.A.
President & CEO
ALDA Pharmaceuticals Corp.
(APH:TSX-V, OTCBB:APCSF)
170 - 4320 Viking Way
Richmond, BC V6V 2L4
604-521-8300 Ext. 207 Phone
604-521-8322 Fax
1-866-521-ALDA (2532)
owen.terrance@gmail.com
www.aldacorp.com

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.